1. Home
  2. CVGI vs ANVS Comparison

CVGI vs ANVS Comparison

Compare CVGI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVGI
  • ANVS
  • Stock Information
  • Founded
  • CVGI 2000
  • ANVS 2008
  • Country
  • CVGI United States
  • ANVS United States
  • Employees
  • CVGI N/A
  • ANVS N/A
  • Industry
  • CVGI Auto Parts:O.E.M.
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVGI Consumer Discretionary
  • ANVS Health Care
  • Exchange
  • CVGI Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • CVGI 58.2M
  • ANVS 55.5M
  • IPO Year
  • CVGI 2004
  • ANVS 2020
  • Fundamental
  • Price
  • CVGI $1.79
  • ANVS $2.74
  • Analyst Decision
  • CVGI
  • ANVS Strong Buy
  • Analyst Count
  • CVGI 0
  • ANVS 4
  • Target Price
  • CVGI N/A
  • ANVS $18.00
  • AVG Volume (30 Days)
  • CVGI 175.7K
  • ANVS 277.6K
  • Earning Date
  • CVGI 08-04-2025
  • ANVS 08-12-2025
  • Dividend Yield
  • CVGI N/A
  • ANVS N/A
  • EPS Growth
  • CVGI N/A
  • ANVS N/A
  • EPS
  • CVGI N/A
  • ANVS N/A
  • Revenue
  • CVGI $676,815,000.00
  • ANVS N/A
  • Revenue This Year
  • CVGI N/A
  • ANVS N/A
  • Revenue Next Year
  • CVGI $7.37
  • ANVS N/A
  • P/E Ratio
  • CVGI N/A
  • ANVS N/A
  • Revenue Growth
  • CVGI N/A
  • ANVS N/A
  • 52 Week Low
  • CVGI $0.81
  • ANVS $1.11
  • 52 Week High
  • CVGI $3.81
  • ANVS $10.54
  • Technical
  • Relative Strength Index (RSI)
  • CVGI 49.76
  • ANVS 52.55
  • Support Level
  • CVGI $1.70
  • ANVS $2.58
  • Resistance Level
  • CVGI $1.94
  • ANVS $2.94
  • Average True Range (ATR)
  • CVGI 0.15
  • ANVS 0.21
  • MACD
  • CVGI -0.01
  • ANVS -0.00
  • Stochastic Oscillator
  • CVGI 48.57
  • ANVS 64.41

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Share on Social Networks: